A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar

BACKGROUND: Mass drug administration (MDA) of praziquantel is one of the main control measures against human schistosomiasis. Although there are claims for including pregnant women, infants and children under the age of 5 years in high-endemic regions in MDA campaigns, they are usually not treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusco, Daniela, Rakotozandrindrainy, Raphäel, Rakotoarivelo, Rivo Andry, Andrianarivelo, Mala Rakoto, Rakotozandrindrainy, Njary, Rasamoelina, Tahinamandranto, Puradiredja, Dewi Ismajani, Klein, Philipp, Stahlberg, Karl, Dechenaud, Marie, Lorenz, Eva, Jaeger, Anna, Kreidenweiss, Andrea, Hoekstra, Pytsje T., Adegnika, Akim Ayola, Sicuri, Elisa, Corstjens, Paul L. A. M., van Dam, Govert J., May, Jürgen, Schwarz, Norbert Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605548/
https://www.ncbi.nlm.nih.gov/pubmed/34801082
http://dx.doi.org/10.1186/s13063-021-05769-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605548/
https://www.ncbi.nlm.nih.gov/pubmed/34801082
http://dx.doi.org/10.1186/s13063-021-05769-6

Ejemplares similares